EKF Diagnostics (LON:EKF) Stock Passes Below 200 Day Moving Average – Here’s Why

EKF Diagnostics Holdings plc (LON:EKF) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 27.22 and traded as low as GBX 26.10. EKF Diagnostics shares last traded at GBX 26.10, with a volume of 244,246 shares traded.

EKF Diagnostics Trading Up 2.4%

The company has a market cap of £113.63 million, a PE ratio of 19.33 and a beta of 0.57. The company has a current ratio of 4.60, a quick ratio of 1.77 and a debt-to-equity ratio of 0.34. The business has a 50 day simple moving average of GBX 25.06 and a two-hundred day simple moving average of GBX 27.22.

Insider Transactions at EKF Diagnostics

In other EKF Diagnostics news, insider Julian Baines purchased 85,000 shares of the firm’s stock in a transaction on Monday, December 15th. The shares were purchased at an average cost of GBX 23 per share, with a total value of £19,550. Insiders own 39.62% of the company’s stock.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

? Point-of-Care analysers in the key areas of Hematology and Diabetes

? Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.